ARCHIVES

Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 3 | March 28, 2003

Download PDF Visit The Full Archive

Related Articles

Dingell To Challenge NCI, NSABP Handling Of Fraud, Delays

April 8, 1994

PDQ Now Offers CME Credit to Physician Users

July 3, 1987

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

NCI Official Says He Hopes to “Put More Money” Into SPOREs.

April 14, 2006

O’Shaughnessy, Burris To Present for Genentech At FDA Hearing At June 28-29

June 10, 2011

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

January 12, 1979